BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 35943269)

  • 1.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0068922. PubMed ID: 35943269
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33288634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of
    Brown Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0007921. PubMed ID: 33846136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
    He G; Wu L; Zheng Q; Jiang X
    Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
    Wallace RJ; Brown-Elliott BA; Crist CJ; Mann L; Wilson RW
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3164-7. PubMed ID: 12234839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kaushik A; Ammerman NC; Martins O; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962331
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Brown-Elliott BA; Wallace RJ
    J Clin Microbiol; 2017 Jun; 55(6):1747-1754. PubMed ID: 28330892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.
    Hershko Y; Adler A
    Microb Drug Resist; 2023 Jul; 29(7):302-308. PubMed ID: 37219996
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Brown-Elliott BA; Rubio A; Wallace RJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126964
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Sun Q; Liao X; Wang C; Jiang G; Yang J; Zhao J; Huang H; Wang G; Li H
    J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35708979
    [No Abstract]   [Full Text] [Related]  

  • 16.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Özkarataş MH; Arslan N; Esen N; Özkütük AA
    Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility testing of tetracycline-class antibiotics against slowly growing non-tuberculous mycobacteria.
    Li A; Tan Z; He S; Chu H
    Clin Exp Pharmacol Physiol; 2023 Jul; 50(7):604-609. PubMed ID: 37086075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.
    Fujiwara K; Uesugi F; Furuuchi K; Tanaka Y; Yoshiyama T; Saotome M; Ohta K; Mitarai S; Morimoto K
    Microbiol Spectr; 2021 Dec; 9(3):e0192821. PubMed ID: 34878300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.